#Daratumumab Effective in Light Chain Amyloidosis  "My experience with this drug is very positive and it [daratumumab] has become our #standard of #care for newly diagnosed patients," commented Mathew Maurer, MD Columbia University   #Genmab $GMAB $JNJ